A new trading day began on Tuesday, with ORIC Pharmaceuticals Inc (NASDAQ: ORIC) stock price down -4.04% from the previous day of trading, before settling in for the closing price of $9.41. ORIC’s price has ranged from $3.90 to $14.67 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 1.57%. With a float of $47.89 million, this company’s outstanding shares have now reached $71.08 million.
In an organization with 115 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 48.97%, operating margin of -27509.01%, and the pretax margin is -24926.27%.
ORIC Pharmaceuticals Inc (ORIC) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of ORIC Pharmaceuticals Inc is 43.81%, while institutional ownership is 69.91%. The most recent insider transaction that took place on Jun 12 ’25, was worth 3,000. In this transaction Chief Financial Officer of this company sold 300 shares at a rate of $10.00, taking the stock ownership to the 101,817 shares. Before that another transaction happened on Jun 11 ’25, when Company’s Chief Financial Officer sold 2,976 for $10.01, making the entire transaction worth $29,777. This insider now owns 102,117 shares in total.
ORIC Pharmaceuticals Inc (ORIC) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 1.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.83% during the next five years compared to -15.32% drop over the previous five years of trading.
ORIC Pharmaceuticals Inc (NASDAQ: ORIC) Trading Performance Indicators
Here are ORIC Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.88, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.73 in one year’s time.
Technical Analysis of ORIC Pharmaceuticals Inc (ORIC)
Let’s dig in a bit further. During the last 5-days, its volume was 0.83 million. That was inferior than the volume of 1.13 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 52.85%. Additionally, its Average True Range was 0.73.
During the past 100 days, ORIC Pharmaceuticals Inc’s (ORIC) raw stochastic average was set at 47.66%, which indicates a significant decrease from 67.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 124.09% in the past 14 days, which was higher than the 103.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.29, while its 200-day Moving Average is $8.36. However, in the short run, ORIC Pharmaceuticals Inc’s stock first resistance to watch stands at $9.36. Second resistance stands at $9.69. The third major resistance level sits at $9.87. If the price goes on to break the first support level at $8.85, it is likely to go to the next support level at $8.67. Assuming the price breaks the second support level, the third support level stands at $8.34.
ORIC Pharmaceuticals Inc (NASDAQ: ORIC) Key Stats
With a market capitalization of 769.57 million, the company has a total of 85,224K Shares Outstanding. Currently, annual sales are 0 K while annual income is -127,850 K. The company’s previous quarter sales were 0 K while its latest quarter income was -30,020 K.
